Department of Psychiatry, University of California San Francisco, San Francisco, California, United States of America.
PLoS One. 2010 Feb 19;5(2):e9325. doi: 10.1371/journal.pone.0009325.
Dysbindin, a cytoplasmic protein long known to function in the biogenesis of specialized lysosome-related organelles (LROs), has been reported to reduce surface expression of D2 dopamine receptors in neurons. Dysbindin is broadly expressed, and dopamine receptors are members of the large family of G protein-coupled receptors (GPCRs) that function in diverse cell types. Thus we asked if dysbindin regulates receptor number in non-neural cells, and further investigated the cellular basis of this regulation.
METHODOLOGY/PRINCIPAL FINDINGS: We used RNA interference to deplete endogenous dysbindin in HEK293 and HeLa cells, then used immunochemical and biochemical methods to assess expression and endocytic trafficking of epitope-tagged GPCRs. Dysbindin knockdown up-regulated surface expression of D2 receptors compared to D1 receptors, as reported previously in neurons. This regulation was not mediated by a change in D2 receptor endocytosis. Instead, dysbindin knockdown specifically reduced the subsequent trafficking of internalized D2 receptors to lysosomes. This distinct post-endocytic sorting function explained the minimal effect of dysbindin depletion on D1 receptors, which recycle efficiently and traverse the lysosomal pathway to only a small degree. Moreover, dysbindin regulated the delta opioid receptor, a more distantly related GPCR that is also sorted to lysosomes after endocytosis. Dysbindin was not required for lysosomal trafficking of all signaling receptors, however, as its depletion did not detectably affect down-regulation of the EGF receptor tyrosine kinase. Dysbindin co-immunoprecipitated with GASP-1 (or GPRASP-1), a cytoplasmic protein shown previously to modulate lysosomal trafficking of D2 dopamine and delta opioid receptors by direct interaction, and with HRS that is a core component of the conserved ESCRT machinery mediating lysosome biogenesis and sorting.
CONCLUSIONS/SIGNIFICANCE: These results identify a distinct, and potentially widespread function of dysbindin in promoting the sorting of specific GPCRs to lysosomes after endocytosis.
Dysbindin 是一种细胞质蛋白,长期以来一直被认为在特殊溶酶体相关细胞器(LRO)的生物发生中发挥作用,据报道它可以减少神经元中 D2 多巴胺受体的表面表达。Dysbindin 广泛表达,而多巴胺受体是 G 蛋白偶联受体(GPCR)大家族的成员,它们在多种细胞类型中发挥作用。因此,我们想知道 dysbindin 是否调节非神经元细胞中的受体数量,并进一步研究这种调节的细胞基础。
方法/主要发现:我们使用 RNA 干扰耗尽 HEK293 和 HeLa 细胞中的内源性 dysbindin,然后使用免疫化学和生化方法评估表位标记的 GPCR 的表达和内吞转运。与先前在神经元中报道的情况一样,dysbindin 敲低会增加 D2 受体的表面表达,而不是 D1 受体。这种调节不是通过 D2 受体内吞作用的变化介导的。相反,dysbindin 敲低特异性地减少了内化的 D2 受体向溶酶体的后续转运。这种独特的出芽后分拣功能解释了 dysbindin 耗竭对 D1 受体的影响很小,因为 D1 受体能够有效地回收并通过溶酶体途径转运,程度很小。此外,dysbindin 调节 delta 阿片受体,一种更远相关的 GPCR,在内吞作用后也被分拣到溶酶体中。然而,dysbindin 并不需要所有信号受体的溶酶体转运,因为其耗竭不会明显影响表皮生长因子受体酪氨酸激酶的下调。Dysbindin 与 GASP-1(或 GPRASP-1)共免疫沉淀,GASP-1 先前被证明通过直接相互作用调节 D2 多巴胺和 delta 阿片受体的溶酶体转运,与 HRS 共沉淀,HRS 是介导溶酶体生物发生和分拣的保守 ESCRT 机制的核心组成部分。
结论/意义:这些结果表明 dysbindin 在促进特定 GPCR 内化后向溶酶体分拣方面具有独特的、潜在广泛的功能。